|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Molina JR, Yang P, Cassivi SD, Schild SE
and Adjei AA: Non-small cell lung cancer: epidemiology, risk
factors, treatment, and survivorship. Mayo Clin Proc. 83:584–594.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Schwartz AG, Wenzlaff AS, Bock CH,
Ruterbusch JJ, Chen W, Cote ML, Artis AS, Van Dyke AL, Land SJ,
Harris CC, et al: Admixture mapping of lung cancer in 1812
African-Americans. Carcinogenesis. 32:312–317. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Alberg AJ and Samet JM: Epidemiology of
lung cancerMurray & Nadel's Textbook of Respiratory Medicine.
Mason RJ, et al: 5th edition. Saunders Elsevier; Amsterdam: pp.
927–939. 2010
|
|
5
|
Matakidou A, Eisen T and Houlston RS:
Systematic review of the relationship between family history and
lung cancer risk. Br J Cancer. 93:825–833. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hung RJ, McKay JD, Gaborieau V, Boffetta
P, Hashibe M, Zaridze D, Mukeria A, SzeszeniaDabrowska N, Lissowska
J, Rudnai P, et al: A susceptibility locus for lung cancer maps to
nicotinic acetylcholine receptor subunit genes on 15q25. Nature.
452:633–637. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang Y, Hua S, Zhang A, Kong X, Jiang C,
Deng D and Wenlong B: Association between polymorphisms in COMT,
PLCH1, and CYP17A1, and non-small-cell lung cancer risk in Chinese
nonsmokers. Clin Lung Cancer. 14:45–49. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tamai K, Semenov M, Kato Y, Spokony R, Liu
C, Katsuyama Y, Hess F, SaintJeannet JP and He X:
LDL-receptor-related proteins in Wnt signal transduction. Nature.
407:530–535. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dieckmann M, Dietrich MF and Herz J:
Lipoprotein receptors - an evolutionarily ancient multifunctional
receptor family. Biol Chem. 391:1341–1363. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Joiner DM, Ke J, Zhong Z, Xu HE and
Williams BO: LRP5 and LRP6 in development and disease. Trends
Endocrinol Metab. 24:31–39. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
MacDonald BT, Tamai K and He X:
Wnt/beta-catenin signaling: components, mechanisms, and diseases.
Dev Cell. 17:9–26. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lee EH, Chari R, Lam A, Ng RT, Yee J,
English J, Evans KG, Macaulay C, Lam S and Lam WL: Disruption of
the non-canonical WNT pathway in lung squamous cell carcinoma. Clin
Med Oncol. 2008.169–179. 2008.PubMed/NCBI
|
|
13
|
Clevers H: Wnt/beta-catenin signaling in
development and disease. Cell. 127:469–480. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Staal FJ and Clevers HC: WNT signalling
and haematopoiesis: a WNT-WNT situation. Nat Rev Immunol. 5:21–30.
2005. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
El Wakil A and Lalli E: The
Wnt/beta-catenin pathway in adrenocortical development and cancer.
Mol Cell Endocrinol. 332:32–37. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu CX, Musco S, Lisitsina NM, Forgacs E,
Minna JD and Lisitsyn NA: LRP-DIT, a putative endocytic receptor
gene, is frequently inactivated in non-small cell lung cancer cell
lines. Cancer Res. 60:1961–1967. 2000.PubMed/NCBI
|
|
17
|
Berrieman HK, Ashman JN, Cowen ME,
Greenman J, Lind MJ and Cawkwell L: Chromosomal analysis of
non-small-cell lung cancer by multicolour fluorescent in situ
hybridisation. Br J Cancer. 90:900–905. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pesch B, Kendzia B, Gustavsson P, Jöckel
KH, Johnen G, Pohlabeln H, Olsson A, Ahrens W, Gross IM, Brüske I,
et al: Cigarette smoking and lung cancer-relative risk estimates
for the major histological types from a pooled analysis of
case-control studies. Int J Cancer. 131:1210–1219. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lindvall C, Evans NC, Zylstra CR, Li Y,
Alexander CM and Williams BO: The Wnt signaling receptor Lrp5 is
required for mammary ductal stem cell activity and Wnt1-induced
tumorigenesis. J Biol Chem. 281:35081–35087. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hoang BH, Kubo T, Healey JH, Sowers R,
Mazza B, Yang R, Huvos AG, Meyers PA and Gorlick R: Expression of
LDL receptor-related protein 5 (LRP5) as a novel marker for disease
progression in high-grade osteosarcoma. Int J Cancer. 109:106–111.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Guo Y, Rubin EM, Xie J, Zi X and Hoang BH:
Dominant negative LRP5 decreases tumorigenicity and metastasis of
osteosarcoma in an animal model. Clin Orthop Relat Res.
466:2039–2045. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Carlson CS, Eberle MA, Rieder MJ, Yi Q,
Kruglyak L and Nickerson DA: Selecting a maximally informative set
of single-nucleotide polymorphisms for association analyses using
linkage disequilibrium. Am J Hum Genet. 74:106–120. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kiel DP, Ferrari SL, Cupples LA, Karasik
D, Manen D, Imamovic A, Herbert AG and Dupuis J: Genetic variation
at the low-density lipoprotein receptor-related protein 5 (LRP5)
locus modulates Wnt signaling and the relationship of physical
activity with bone mineral density in men. Bone. 40:587–596. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
CantoCetina T, Polanco Reyes L, González
Herrera L, Rojano-Mejía D, Coral-Vázquez RM, Coronel A and Canto P:
Polymorphism of LRP5, but not of TNFRSF11B, is associated with a
decrease in bone mineral density in postmenopausal maya-mestizo
women. Am J Hum Biol. 25:713–718. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Falcón-Ramírez E, Casas-Avila L,
Cerda-Flores RM, Castro-Hernández C, Rubio-Lightbourn J,
Velázquez-Cruz R, Diez-G P, Peñaloza-Espinosa R and Valdés-Flores
M: Association of LRP5 haplotypes with osteoporosis in Mexican
women. Mol Biol Rep. 40:2705–2710. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Massart F, Marini F, Bianchi G, Minisola
S, Luisetto G, Pirazzoli A, Salvi S, Micheli D, Miccoli M, Baggiani
A, et al: Genetic predictors of skeletal outcomes in healthy
fertile women: the Bonturno study. Joint Bone Spine. 80:414–419.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Funakoshi Y, Omori H, Yada H and Katoh T:
A1330V polymorphism of the low-density lipoprotein receptor-related
protein 5 gene and bone mineral density in Japanese male workers.
Environ Health Prev Med. 16:106–112. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jiang XY, Chen Y, Xu L, Li X, Cao FF, Li
L, Lu M, Jin L and Wang XF: Association of LPR5 polymorphism with
bone mass density and cholesterol level in population of Chinese
Han. Exp Clin Endocrinol Diabetes. 118:388–391. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang YP, Deng FY, Chen Y, Pei YF, Fang Y,
Guo YF, Guo X, Liu XG, Zhou Q, Liu YJ and Deng HW: Replication
study of candidate genes/loci associated with osteoporosis based on
genome-wide screening. Osteoporos Int. 21:785–795. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jiang XY, Chen HH, Cao FF, Li L, Lin RY,
Wen H, Jin L and Wang XF: A polymorphism near osteoprotegerin gene
confer risk of obesity in Uyghurs. Endocrine. 37:383–388. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang CW, Li CI, Liu CS, Bau DT, Lin CH,
Lin WY, Li TC and Lin CC: The joint effect of cigarette smoking and
polymorphisms on LRP5, LEPR, near MC4R and SH2B1 genes on metabolic
syndrome susceptibility in Taiwan. Mol Biol Rep. 40:525–533. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Frusch N, Bosquée L and Louis R: Lung
cancer. Epidemiology and etiologic factors. Rev Med Liege.
62:548–553. 2007.(In French). PubMed/NCBI
|
